Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.

Literature DB >> 2510597

Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.

B A Brown¹, R J Wallace, C W Flanagan, R W Wilson, J I Luman, S D Redditt.

Abstract

We reviewed tetracycline and erythromycin disk diffusion susceptibility of 457 isolates of Branhamella catarrhalis. Four isolates were resistant to tetracycline, with MICs for two available isolates of 16 micrograms/ml. Sixteen isolates were in the moderately susceptible range for erythromycin, with an MIC for one available isolate being greater than 8 micrograms/ml. These are the first tetracycline- and (by MIC) erythromycin-resistant B. catarrhalis isolates reported from the United States.

Entities: Chemical Species

Mesh：

Substances：

Year: 1989 PMID： 2510597 PMCID： PMC172719 DOI： 10.1128/AAC.33.9.1631

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

20 in total

1. In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.

Authors: S Alvarez; M Jones; S Holtsclaw-Berk; J Guarderas; S L Berk
Journal: Antimicrob Agents Chemother Date: 1985-04 Impact factor: 5.191

2. Plasmid profiles of Moraxella bovis isolates.

Authors: T J McDonald; G W Pugh
Journal: Am J Vet Res Date: 1986-04 Impact factor: 1.156

Review 3. Antimicrobial susceptibility testing of Haemophilus influenzae, Branhamella catarrhalis, and Neisseria gonorrhoeae.

Authors: G V Doern; R N Jones
Journal: Antimicrob Agents Chemother Date: 1988-12 Impact factor: 5.191

4. Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.

Authors: F Ahmad; D T McLeod; M J Croughan; M A Calder
Journal: Antimicrob Agents Chemother Date: 1984-09 Impact factor: 5.191

5. Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media.

Authors: C Kamme
Journal: Scand J Infect Dis Date: 1970

6. Amoxycillin-clavulanic acid combination in bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis. Preliminary report.

Authors: P E Thornley; J M Aitken; G M Nichol; N J Slevin
Journal: Drugs Date: 1986 Impact factor: 9.546

7. Branhamella catarrhalis respiratory infections in The Netherlands.

Authors: F P Maesen; B I Davies
Journal: Drugs Date: 1986 Impact factor: 9.546

8. Sensitivity of Branhamella catarrhalis to oral antibiotics.

Authors: I Kallings
Journal: Drugs Date: 1986 Impact factor: 9.546

9. Clinical and bacteriological evaluation of Branhamella catarrhalis in respiratory infections.

Authors: A Saito; K Yamaguchi; Y Shigeno; S Kohno; H Shigeno; N Kusano; Y Dotsu; K Hara
Journal: Drugs Date: 1986 Impact factor: 9.546

10. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease.

Authors: J A Pollard; R J Wallace; D R Nash; J I Luman; R W Wilson
Journal: Drugs Date: 1986 Impact factor: 9.546

9 in total

1. Genetic basis of tetracycline resistance in Moraxella (Branhamella) catarrhalis.

Authors: M C Roberts; B A Brown; V A Steingrube; R J Wallace
Journal: Antimicrob Agents Chemother Date: 1990-09 Impact factor: 5.191

2. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.

Authors: G V Doern; A B Brueggemann; G Pierce; T Hogan; H P Holley; A Rauch
Journal: Antimicrob Agents Chemother Date: 1996-12 Impact factor: 5.191

Review 3. Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors: B W Catlin
Journal: Clin Microbiol Rev Date: 1990-10 Impact factor: 26.132

4. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.

Authors: J H Jorgensen; G V Doern; L A Maher; A W Howell; J S Redding
Journal: Antimicrob Agents Chemother Date: 1990-11 Impact factor: 5.191

Review 5. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors: K McGregor; B J Chang; B J Mee; T V Riley
Journal: Eur J Clin Microbiol Infect Dis Date: 1998-04 Impact factor: 3.267

6. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.

Authors: B A Brown; R J Wallace; G Onyi
Journal: Antimicrob Agents Chemother Date: 1996-04 Impact factor: 5.191

7. Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis.

Authors: M C Roberts; Y J Pang; R C Spencer; T G Winstanley; B A Brown; R J Wallace
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191

8. Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.

Authors: S C Sehgal; I al Shaimy
Journal: Infection Date: 1994 May-Jun Impact factor: 3.553

9. Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.

Authors: D R Nash; C Flanagan; L C Steele; R J Wallace
Journal: Antimicrob Agents Chemother Date: 1991-01 Impact factor: 5.191

9 in total